Thank you to the attendees, faculty, sponsors, and supporters of the Psychopharmacology Update for making the conference a tremendous success!  We hope to see you again in 2020. SIGN UP for email updates to keep informed of program developments for our upcoming conference as they become available.



Friday, October 25, 2019

Optional, Pre-conference Workshops

10:00 AM - 1:15 PM 

Optional Workshop: Addiction

Director: Edwin Salsitz, MD

1:15 PM

Lunch (Please note: This lunch and lunch symposium are open to attendees of either workshop, but only to workshop attendees.)

1:30 PM – 2:15 PM

Lunch Symposium (Non-CME)
An Update on the Management of Depressive, Manic, and Mixed Episodes of Bipolar I Disorder
Faculty: Paul E Keck, MD
Sponsored by: Allergan

2:30 PM - 5:45 PM

Optional Workshop: Medical Cannabis for Psychiatrists: Science and Practice

Director: Kevin P. Hill, MD


Saturday, October 26, 2019

General Sessions

Recent Breakthroughs in Psychopharmacology: Novel Treatments

6:45 AM

Registration /Breakfast /Exhibits

7:10 - 8:10 AM

Breakfast Symposium (Non-CME)
Beyond the Dopamine Hypothesis: The Role of Other Neurotransmitters in Schizophrenia
Faculty: Andrew J. Cutler, MD
Sponsored by: Intra-Cellular Therapies

8:15 – 8:30 AM

Welcome and Course Overview
Henry A. Nasrallah, MD

8:30 – 9:15 AM

A Breakthrough Treatment for Postpartum Depression
Ruta M. Nonacs, MD, PhD

9:15 – 10:30 AM

Morning Symposium (1.25 Additional CME)
Fact or Fiction? Test Your Knowledge of Bipolar Depression
Faculty: Melissa DelBello, MD, MS and Martha Sajatovic, MD
This activity is jointly provided by Medical Education Resources and CMEology.
This symposium is supported by an educational grant from Sunovion Pharmaceuticals Inc.

10:30 – 10:45 AM


10:45 – 11:30 AM

Esketamine for Treatment-Resistant Depression
James W. Murrough, MD

11:30 AM – 12:15 PM

Long-Acting Injectables Antipsychotics for Psychotic and Mood Disorders
Leslie Citrome, MD, MPH

12:15 – 12:30 PM

Q&A Panel with Faculty

12:30 – 12:45 PM


12:45 – 1:45 PM

Lunch Symposium (Non-CME)
Bipolar Depression in Adults: Presentation, Diagnosis, and Treatment - The Pervasive Impact on Patients' Lives
Faculty: Azfar Malik, MD, MBA, DFAPA
Sponsored by: Sunovion Pharmaceuticals Inc

1:45 – 2:00 PM

Dessert Break/Exhibits

2:00 – 2:45 PM

Psychedelic Assisted Therapy as a Novel Treatment for Depression, Anxiety, and PTSD
Andrew Penn, RN, MS, PMHNP-BC

2:45 – 3:45 PM

Afternoon Symposium (1.0 Additional CME Credit)
Timely Recognition and Management of Patients with Tardive Dyskinesia in Psychiatric Practice: Differentiating Options for Optimized Patient Care
Activity Chair:  Leslie Citrome, MD, MPH
Faculty: Stephen R. Saklad, PharmD, BCPP
This continuing medical education activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from Neurocrine Biosciences, Inc.

3:45 – 4:15 PM

Botulinum Toxic for Depression
Michelle Magid, MD, MBA

4:15 – 5:00 PM

Treating Parkinson's Disease Psychosis with a Non-Dopaminergic Agent
Alberto J. Espay, MD, MSc

5:00 – 5:45 PM

What to do when Clozapine Fails in Refractory Psychosis? 
Henry A. Nasrallah, MD

5:45 – 6:00 PM

Q&A Panel with Faculty



Follow Us

Jointly Provided By